Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 7:26 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 313–336 of 365 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Obsessive Compulsive Disorder (OCD) Clear all

Conditions: Obsessive-Compulsive Disorder
Interventions: Project EMPOWER-OCD, Project CARE; Behavioral
Lead sponsor: Boston University Charles River Campus; Other
Eligibility: 18 Years and older
Enrollment: 110 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Claustrophobia, Obsessive-Compulsive Disorder, Arachnophobia
Interventions: Experimental Scent, Control Scent, No-Scent Control, In-Vivo Exposure; Other · Behavioral
Lead sponsor: University of Texas at Austin; Other
Eligibility: 18 Years to 65 Years
Enrollment: 158 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Anxiety Disorders, Obsessive Compulsive Disorder, PTSD
Interventions: Internet Based CBT Training; Behavioral
Lead sponsor: Center for Psychological Consultation; Other
Eligibility: 18 Years and older
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Anxiety Disorders, Post Traumatic Stress Disorder, Obsessive-Compulsive Disorder
Interventions: Standard UP Treatment, Capitalization UP Treatment, Compensation UP Treatment; Behavioral
Lead sponsor: Shannon E. Sauer-Zavala; Other
Eligibility: 18 Years and older
Enrollment: 61 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Obsessive Compulsive Disorder (OCD), Neuromodulation
Interventions: Deep Brain Stimulation; Device
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 22 Years to 64 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2030
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Anxiety, Obsessive Compulsive Disorder
Interventions: Virtual Reality; Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 7 Years to 12 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Obsessive-Compulsive Disorder
Interventions: ACT plus ERP, ERP alone; Behavioral
Lead sponsor: Utah State University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 58 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2017
U.S. locations: 2
States / cities: Chapel Hill, North Carolina • Logan, Utah

Conditions: Obsessive-Compulsive Disorder
Interventions: dextro-amphetamine, Sham Comparison; Drug
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 55 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: Stanford, California

Conditions: Obsessive-Compulsive Disorder
Interventions: Troriluzole, Placebo; Drug
Lead sponsor: Biohaven Pharmaceuticals, Inc.; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 456 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 73
States / cities: Chandler, Arizona • Phoenix, Arizona • Bellflower, California + 62 more

Conditions: Obsessive-compulsive Disorder
Interventions: topiramate; Drug
Lead sponsor: Montefiore Medical Center; Other
Eligibility: 18 Years to 65 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2006
U.S. locations: 1
States / cities: New York, New York

Conditions: Anxiety Disorders, Generalized Anxiety Disorder, Social Anxiety Disorder, Obsessive-Compulsive Disorder
Interventions: Psycho-social, computerized intervention targeting error sensitivity, Psycho-social, computerized intervention on healthy lifestyle choices; Behavioral
Lead sponsor: Florida State University; Other
Eligibility: 9 Years to 12 Years
Enrollment: 248 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Tallahassee, Florida

Conditions: Trichotillomania
Interventions: Keen2 bracelet, Reminder bracelet, Keen2 app, Health Reminders App; Device · Behavioral
Lead sponsor: HabitAware Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Kent, Ohio

Conditions: Obsessive-Compulsive Disorder
Interventions: Stereoencephalography (SEEG), Deep Brain Stimulation (DBS); Device
Lead sponsor: Casey H. Halpern, M.D.; Other
Eligibility: 22 Years to 75 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2030
U.S. locations: 2
States / cities: Stanford, California • Philadelphia, Pennsylvania

Conditions: Obsessive-Compulsive Disorder
Interventions: Medtronic Percept Deep Brain Stimulation Therapy [Sham Control Stimulation], Medtronic Percept Deep Brain Stimulation Therapy [Therapeutic stimulation]; Device
Lead sponsor: Nader Pouratian; Other
Eligibility: 22 Years to 75 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Excoriation (Skin-Picking) Disorder
Interventions: Acceptance-Enhanced Behavior Therapy; Behavioral
Lead sponsor: Utah State University; Other
Eligibility: 18 Years and older
Enrollment: 84 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Logan, Utah

Conditions: Obsessive-compulsive Disorder (OCD)
Interventions: Psilocybin 100 mcg/kg, Psilocybin 300 mcg/kg, Lorazepam 1 mg; Drug
Lead sponsor: University of Arizona; Other
Eligibility: 18 Years to 65 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Tucson, Arizona

Conditions: Generalized Anxiety Disorder (GAD), Social Anxiety Disorder (SAD), Separation Anxiety Disorder, Specific Phobia, Obsessive Compulsive Disorder (OCD), Panic Disorder (With or Without Agoraphobia)
Interventions: Relaxation and Mentorship Training (RMT), Stepped Care Targeting Exposure and Parenting for Anxiety (STEP-A); Behavioral
Lead sponsor: Andrew Wiese; Other
Eligibility: 7 Years to 17 Years
Enrollment: 106 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Obsessive Compulsive Disorder
Interventions: Ketamine, Midazolam; Drug
Lead sponsor: Wayne Goodman MD; Other
Eligibility: 21 Years to 65 Years
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: New York, New York

Conditions: Obsessive Compulsive Disorder
Interventions: Behavioral Checklist; Behavioral
Lead sponsor: Rhode Island Hospital; Other
Eligibility: 5 Years to 17 Years
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2018
U.S. locations: 1
States / cities: East Providence, Rhode Island

Conditions: Obsessive-compulsive Disorders and Symptoms in Children
Interventions: Cognitive Behavioral Therapy, Community Referral as appropriate; Behavioral · Other
Lead sponsor: University of Michigan; Other
Eligibility: 6 Years to 14 Years
Enrollment: 169 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2023
U.S. locations: 2
States / cities: Ann Arbor, Michigan • New York, New York

Conditions: Obsessive Compulsive Disorder
Interventions: Minocycline, Placebo; Drug · Other
Lead sponsor: New York State Psychiatric Institute; Other
Eligibility: 8 Years to 20 Years
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2018
U.S. locations: 2
States / cities: New York, New York

Conditions: Obsessive-Compulsive Disorder
Interventions: Cognitive Behavioral Treatment; Behavioral
Lead sponsor: Boston University Charles River Campus; Other
Eligibility: 18 Years and older
Enrollment: 52 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2008
U.S. locations: 2
States / cities: Hartford, Connecticut • Boston, Massachusetts

Conditions: Obsessive-Compulsive Disorder
Interventions: behavior therapy, D-Cycloserine; Behavioral · Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2007
U.S. locations: 2
States / cities: Hartford, Connecticut • Boston, Massachusetts

Conditions: Obsessive-Compulsive Disorder (OCD)
Interventions: Intensive Cognitive Behavioral Therapy (CBT), Waitlist; Behavioral
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years to 65 Years
Enrollment: 75 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2015
U.S. locations: 1
States / cities: Los Angeles, California

Search by objective public record fields.

Project EMPOWER-OCD

Efficacy of Targeted Memory Reactivation for Enhancing Exposure Therapy

Web Based Therapist Training on Cognitive Behavior Therapy for Anxiety Disorders

Increasing Treatment Efficacy Using SMART Methods for Personalizing Care

Neurophysiological Investigation of the Approach-avoidance Axis in OCD: Applications to Neuromodulation

Virtual Reality System to Increase Access to Exposure Therapy for Anxiety and OCD

Combining Acceptance and Commitment Therapy With Exposure and Response Prevention to Enhance Treatment Engagement

Dextro-Amphetamine Versus Caffeine in Treatment-resistant OCD

Efficacy and Safety Study of Adjunctive Troriluzole in Obsessive Compulsive Disorder

Topiramate Augmentation in the Treatment of Obsessive-Compulsive Disorder

Computerized Intervention Targeting the Error-Related Negativity and Balance N1 in Anxious Children

Technology Assisted Treatment for Trichotillomania

SEEG-Guided DBS for OCD

Deep Brain Stimulation for Refractory Obsessive-Compulsive Disorder

A RCT of an AEBT Website for Adults With Skin Picking

Psilocybin for Treatment of Obsessive Compulsive Disorder

Stepped Care Treatment for Anxiety Resilience

Intravenous Ketamine in the Treatment of Obsessive-Compulsive Disorder

CBT for Pediatric OCD: Community Training Pilot

Task Control Circuit Targets for Obsessive Compulsive Behaviors in Children

Novel Medication Strategies Targeting Brain Mechanisms in Pediatric OCD

Pilot Trial of Cognitive and Behavioral Treatment of Compulsive Hoarding Compared to Wait List Control

A Medication Trial Combined With Behavior Therapy for Individuals With Obsessive-compulsive Disorder

Intensive Cognitive-Behavioral Therapy For Obsessive-Compulsive Disorder